View All Documents & Correspondence
Ophthalmic Compositions And Methods For The Treatment Of Eye Disorders And Skin Diseases
Abstract: The invention relates to the compounds or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, formula II, formula III, formula IV, formula V and formula VI and the methods for the treatment of eye disorders and skin diseases and may be formulated for the topical eye drop, topical paste, ocular solution, device-drug delivery, oral, buccal, rectal, topical, transdermal, transmucosal, lozenge, spray, intravenous, oral solution, nasal spray, oral solution, cream, dermal ointment, gels, lotions, suspension, oral spray, buccal mucosal layer tablet, parenteral administration, syrup, or injection. Such compositions may be used to treatment of skin diseases such as acne, rosacea and eye disorders such as ocular redness, glaucoma, presbyopia, IOP, cataract, dry eye and oGVHD.
Notices, Deadlines & Correspondence
Patent Information
Applicants
CELLIX BIO PRIVATE LIMITED
Inventors
1. KANDULA, Mahesh
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202147006224-STATEMENT OF UNDERTAKING (FORM 3) [15-02-2021(online)].pdf | 2021-02-15 |
| 2 | 202147006224-PROOF OF RIGHT [15-02-2021(online)].pdf | 2021-02-15 |
| 3 | 202147006224-PRIORITY DOCUMENTS [15-02-2021(online)].pdf | 2021-02-15 |
| 4 | 202147006224-POWER OF AUTHORITY [15-02-2021(online)].pdf | 2021-02-15 |
| 5 | 202147006224-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105) [15-02-2021(online)].pdf | 2021-02-15 |
| 6 | 202147006224-FORM FOR SMALL ENTITY(FORM-28) [15-02-2021(online)].pdf | 2021-02-15 |
| 7 | 202147006224-FORM 1 [15-02-2021(online)].pdf | 2021-02-15 |
| 8 | 202147006224-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [15-02-2021(online)].pdf | 2021-02-15 |
| 9 | 202147006224-DRAWINGS [15-02-2021(online)].pdf | 2021-02-15 |
| 10 | 202147006224-DECLARATION OF INVENTORSHIP (FORM 5) [15-02-2021(online)].pdf | 2021-02-15 |
| 11 | 202147006224-COMPLETE SPECIFICATION [15-02-2021(online)].pdf | 2021-02-15 |
| 12 | 202147006224-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [15-02-2021(online)].pdf | 2021-02-15 |
| 13 | 202147006224-Correspondence_Form1, Power of Attorney_01-03-2021.pdf | 2021-03-01 |
| 14 | 202147006224-FORM 3 [03-07-2021(online)].pdf | 2021-07-03 |
| 15 | 202147006224.pdf | 2021-10-18 |
| 16 | 202147006224-FORM 3 [02-12-2021(online)].pdf | 2021-12-02 |
| 17 | 202147006224-FORM 18 [16-08-2022(online)].pdf | 2022-08-16 |
| 18 | 202147006224-FER.pdf | 2022-09-07 |
| 19 | 202147006224-RELEVANT DOCUMENTS [06-03-2023(online)].pdf | 2023-03-06 |
| 20 | 202147006224-POA [06-03-2023(online)].pdf | 2023-03-06 |
| 21 | 202147006224-FORM 13 [06-03-2023(online)].pdf | 2023-03-06 |
| 22 | 202147006224-OTHERS [07-03-2023(online)].pdf | 2023-03-07 |
| 23 | 202147006224-Information under section 8(2) [07-03-2023(online)].pdf | 2023-03-07 |
| 24 | 202147006224-FORM 3 [07-03-2023(online)].pdf | 2023-03-07 |
| 25 | 202147006224-FER_SER_REPLY [07-03-2023(online)].pdf | 2023-03-07 |
| 26 | 202147006224-DRAWING [07-03-2023(online)].pdf | 2023-03-07 |
| 27 | 202147006224-CORRESPONDENCE [07-03-2023(online)].pdf | 2023-03-07 |
| 28 | 202147006224-COMPLETE SPECIFICATION [07-03-2023(online)].pdf | 2023-03-07 |
| 29 | 202147006224-CLAIMS [07-03-2023(online)].pdf | 2023-03-07 |
| 30 | 202147006224-US(14)-HearingNotice-(HearingDate-22-12-2023).pdf | 2023-11-06 |
Search Strategy
| 1 | Search202147006224E_06-09-2022.pdf |
| 2 | inpassE_06-09-2022.pdf |